581 results on '"Oesterling, Joseph E."'
Search Results
2. Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomy
3. Diagnosis and Treatment of Benign Prostatic Hyperplasia: Practice Patterns of Primary Care Physicians
4. Interpreting results of prostate-specific antigen testing for early detection of prostate cancer
5. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update
6. The definition and preoperative prediction of clinically insignificant prostate cancer
7. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing
8. Benign prostatic hyperplasia: medical and minimally invasive treatment options
9. Megestrol acetate for the prevention of hot flashes
10. Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges
11. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer
12. Cancer of the prostate
13. Transurethral Needle Ablation of the Prostate: A Minimally Invasive Treatment for Symptomatic Benign Prostatic Hyperplasia
14. Serum Percent–Free PSA Does Not Predict Extraprostatic Spread of Prostate Cancer
15. Predicting Pathological Stage of Localized Prostate Cancer
16. FALSE POSITIVE RATE OF PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN A COMMUNITY BASED POPULATION
17. LONG-TERM RESULTS OF A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL COMPARING TUNA® TO TURP FOR THE TREATMENT OF SYMPTOMATIC BPH
18. CHANGES IN PROSTATE-SPECIFIC ANTIGEN (PSA) AND DIHYDROTESTERONE (DHT) IN A POPULATION OF HEALTHY, AGING MEN
19. Predictive Properties of Serum Prostate-Specific Antigen Testing in a Community Setting
20. The Decision to Seek Care: Factors Associated With the Propensity to Seek Care in a Community-Based Cohort of Men
21. Percent Free Prostate-Specific Antigen: Entering a New Era in the Detection of Prostate Cancer
22. Prostate-Specific Antigen in Black Men
23. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians amd urologists
24. Benign prostatic hyperplasia: use of drug therapy in primary care
25. Predictive Properties of Serum Prostate-Specific Antigen Testing in a Community-Based Setting
26. Age-Specific Reference Ranges for Serum PSA
27. Defining Clinically Insignificant Prostate Cancer
28. In Reply: PSA Screening and Prostate Cancer Incidence
29. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study
30. Treatment of Benign Prostatic Hyperplasia
31. New Diagnostic and Treatment Guidelines for Benign Prostatic Hyperplasia: Potential Impact in the United States
32. Drug Therapy: Benign Prostatic Hyperplasia: Medical and Minimally Invasive Treatment Options
33. BPH management: minimal to maximal
34. Age-Specific Reference Ranges for Prostate-Specific Antigen.
35. Prostate specific antigen: its role in the diagnosis and staging of prostate cancer
36. DISCRIMINATION OF MEN WITH PROSTATE CANCER FROM THOSE WITH BENIGN DISEASE BY MEASUREMENTS OF HUMAN GLANDULAR KALLIKREIN 2 (HK2) IN SERUM
37. Predicting pathological stage of localized prostate cancer
38. HAVE COMPLICATION RATES DECREASED AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER?
39. PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOING
40. Hormonal Therapy of Prostate Cancer: Limitations in the Total Androgen Ablation Concept
41. Radical Prostatectomy for the Treatment of Localized Prostatic Cancer
42. Prostate-specific antigen: improving its ability to diagnose early prostate cancer
43. Medical malpractice implications of PSA testing for early detection of prostate cancer
44. Defining clinically insignificant prostate cancer
45. PSA screening and prostate cancer incidence
46. Age-specific reference ranges for prostate-specific antigen
47. Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomy
48. PROSTATE SPECIFIC ANTIGEN
49. BLADDER NECK-SPARING TECHNIQUE ADVERSELY AFFECTS ANTI-TUMOR EFFICACY OF RADICAL PROSTATECTOMY IN PATHOLOGIC T3a PROSTATE CANCER
50. THE IMPACT OF BLADDER NECK SPARING AND NERVE SPARING ON URINARY FUNCTION AND CANCER CONTROL ASSOCIATED WITH RADICAL PROSTATECTOMY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.